Screener
Lifecore Biomedical, Inc. LFCR Ratios & Valuation
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 3.9×— | 3.8×+0.9× | 3.5×+0.8× | 2.8×+0.5× | —— | |
| Per Share | ||||||
| Book value per share | -$0.91— | -$0.76-2,202% | —— | -$0.28-163% | —— | |
| Valuation | ||||||
| Market capitalization | $176.02M-37.5% | $188.3M-27.3% | $269.76M+24.8% | $295.98M+29.5% | $284.67M+113% |
FAQ
- What are Lifecore Biomedical, Inc.'s profit margins?
- Lifecore Biomedical, Inc. (LFCR) runs a 31.3% gross margin and a -13.4% operating margin, with a -30.0% net margin.
- Where do Lifecore Biomedical, Inc.'s ratios come from?
- Every ratio is computed from Lifecore Biomedical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
